Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Inventiva, a biopharmaceutical company, will present four abstracts related to digital pathology at the upcoming American Association for the Study of…
The biopharmaceutical company's stock closed lower this Thursday, despite several recent communications.
The biopharmaceutical company's stock closed the session on Wednesday, October 15 at €3.64, down 9% from the previous day when it traded at €4. This d…
The French biotech specializing in the treatment of MASH closed sharply lower on Monday, extending a significant weekly correction.
The French biotech recorded a 5.82% increase this Tuesday, closing at €4.00, while the CAC 40 slightly declined by 0.18%.
The share price of the biopharmaceutical company specializing in the development of oral therapies for the treatment of MASH closed at €3.9850, signif…
